Biotechnology in India: Public–private partnerships

Journal of Commercial Biotechnology
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology

Biotechnology in India: Public–private partnerships

Go to paper

ABSTRACT: As the purpose of this study was a survey of public sector–private industry collaborations of the biotechnology sector in India, an organisational and functional overview of this sector was needed. Therefore, rather than studying a hypothetical biotech sector in India, the focus of this work was to study the public–private partnerships (PPP) that are occurring in India in the area of modern biotechnology…

The Journal of Commercial Biotechnology is a unique forum for all those involved in biotechnology commercialization to present, share, and explore new ideas, latest thinking and best practices, making it an indispensable guide for those developing projects and careers within this fast moving field.

Each issue publishes peer-reviewed, authoritative, cutting-edge articles written by the leading practitioners and researchers in the field, addressing topics such as:

  • Management
  • Policy
  • Finance
  • Law
  • Regulation
  • Bioethics

For more information, see the Journal of Commercial Biotechnology website


Assessing the history and value of Human Genome Sciences

Journal of Commercial Biotechnology
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology

Assessing the history and value of Human Genome Sciences

Go to paper

ABSTRACT: Human Genome Science (HGS) aspired to dominate the emergent field of genomics by discovering expressed gene sequences and developing therapeutic and diagnostic products based on proprietary genes. While HGS’ accomplishments fell short of their own lofty expectations, by the time HGS was acquired by GlaxoSmithKline, the company had extensive intellectual property and had launched a product with >$1 billion market potential…

The Journal of Commercial Biotechnology is a unique forum for all those involved in biotechnology commercialization to present, share, and explore new ideas, latest thinking and best practices, making it an indispensable guide for those developing projects and careers within this fast moving field.

Each issue publishes peer-reviewed, authoritative, cutting-edge articles written by the leading practitioners and researchers in the field, addressing topics such as:

  • Management
  • Policy
  • Finance
  • Law
  • Regulation
  • Bioethics

For more information, see the Journal of Commercial Biotechnology website


Social Network Analysis of Pharmaceutical Innovation

I was just notified of a fascinating paper citing my research from DrugPatentWatch.com. Briefly, I found two surprising results: Firstly, pharmaceutical innovation has been essentially immobile — it remains almost completely rooted in the United States and Western Europe. Secondly, there is virtually no innovation coming out of so-called emerging economies such as India and China (i.e. <1% as […]


Biotechnology in Countries Starting with “I” – Part 7: India

This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below. For the next chapter in this continuing series, let’s turn back to India and the draft National IPR Policy currently under debate in New Delhi. A great deal […]


What will it take to get institutional investors interested in life sciences again?

This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
What will it take to get institutional investors interested in life sciences again?
Go to paperABSTRACT: With the European biotechnology market nearing a…


Growth of Indian biotech companies, in the context of the international biotechnology industry

This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Growth of Indian biotech companies, in the context of the international biotechnology industry
Go to paperABSTRACT: The paper discusses the evolution and…


Technology transfer in the biomedical sciences: The Medical Research Council approach

This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Technology transfer in the biomedical sciences: The Medical Research Council approach
Go to paperABSTRACT: This paper describes why the UK Medical Resear…


New CMS Guidance for Biotech Industry On Coverage With Evidence Development: It’s All About The Outcomes

This is a guest post from Robert E. Wanerman, a member of Epstein Becker Green’s Health Care and Life Sciences practice. Do you have a response to Robert’s post? Respond in the comments section below. For many biotech manufacturers, obtaining Medicare coverage is a significant milestone in commercializing an item or service. Although Medicare coverage […]